BGLC

BioNexus Gene Lab (QB) Stock Price

2.29
-0.01 (-0.43%)
2.29
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
BioNexus Gene Lab Corporation (QB) BGLC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.43% 2.29 16:00:07
Open Price Low Price High Price Close Price Prev Close
2.29 2.29 2.29 2.29 2.30
Bid Price Ask Price Spread News
1.70 2.50 0.80 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1 100 $ 2.29 $ 229 - 0.36 - 3.35
Last Trade Time Type Quantity Stock Price Currency
15:09:14 100 $ 2.29 USD

BioNexus Gene Lab (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 392.09M 171.22M 11.15M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
100.00 $ - 0.00% - -

more financials information »

BioNexus Gene Lab (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BGLC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.692.692.292.30600-0.40-14.87%
1 Month2.302.691.652.10548-0.01-0.43%
3 Months2.4913.001.062.13782-0.201-8.07%
6 Months0.363.350.361.352,0981.93536.11%
1 Year0.363.350.361.352,0981.93536.11%
3 Years0.363.350.361.352,0981.93536.11%
5 Years0.363.350.361.352,0981.93536.11%

BioNexus Gene Lab (QB) Description

We are an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. We were incorporated in the State of Wyoming on May 12, 2017. On August 23, 2017, we acquired all of the outstanding capital stock of BioNexus Gene Lab Sdn Bhd., a Malaysian corporation ("Subsidiary"). The Subsidiary was incorporated in Malaysia on April 7, 2015. The Subsidiary owns algorithm software, technology and know how related to the detection of common diseases through blood analysis which we use in our business.


Your Recent History
USOTC
BGLC
BioNexus G..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.